Fungal Infections in Immunocompromised Hosts
Fungal infections can be life-threatening in people with weak immune systems, such as transplant recipients, cancer patients and people with advanced HIV. Diagnosis is often difficult and treatment options are limited.
The Fungal Infections in Immunocompromised Hosts session at Infectious 2027 covers research on these serious infections. It links closely with microbiology and immunology, which explains how the immune system fights fungi.
Fungal infections are often overlooked but can be deadly in people with weak immunity. Patients with cancer, transplants or advanced HIV are most at risk. Symptoms can be vague, making diagnosis difficult. Early treatment greatly improves the chance of survival.
Key Topics in Fungal Infections in Immunocompromised Hosts
• Invasive aspergillosis
• Invasive candidiasis and Candida auris
• Cryptococcal meningitis
• Mucormycosis
• Pneumocystis pneumonia
• Endemic fungal infections in Asia
• Antifungal resistance
• Antifungal prophylaxis and stewardship
• Fungal diagnostics
• New antifungal drugs
Recent Advances in Fungal Infections in Immunocompromised Hosts
Candida auris, a drug-resistant yeast, has spread to hospitals worldwide, prompting new infection control measures from infectious diseases prevention, control and cure. New antifungal drugs are reaching patients after years with few new options.
Better tests for fungal infections, covered in diagnostic innovations in infectious diseases, are helping diagnose infections earlier. People with HIV, discussed in HIV/AIDS research and treatment advances, remain at high risk of cryptococcal disease.
New antifungal drugs are giving doctors more options. Faster tests are helping detect fungal infections earlier. Hospitals are improving infection control to stop the spread of resistant fungi. Global health bodies are raising awareness of fungal threats.
Who Should Attend the Fungal Infections in Immunocompromised Hosts Session
• Infectious disease physicians and microbiologists
• Haematologists and transplant specialists
• Critical care physicians
• Antimicrobial pharmacists
• PhD students and early-career researchers
• Mycology researchers
Why Present Your Research in Fungal Infections in Immunocompromised Hosts
Presenting at Infectious 2027 puts your fungal research in front of an international audience. You can connect with colleagues in pediatric infectious diseases management treating children with weak immunity. Fungal infection research is a growing field. Sharing your work here helps raise awareness and improve care.
Frequently Asked Questions
Can I present Candida auris research?
Yes. Candida auris and antifungal resistance are key topics.
Are fungal case reports welcome?
Yes. Case reports with clear learning points are welcome.
When is Infectious 2027?
Infectious 2027 runs from 11 to 13 March 2027 at Village Hotel Changi, Singapore, and online.